These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35160265)

  • 1. Motor-Independent Cognitive Testing in Motor Degenerative Diseases.
    Schmitz-Peiffer H; Aust E; Linse K; Rueger W; Joos M; Löhle M; Storch A; Hermann A
    J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study.
    Keller J; Gorges M; Horn HT; Aho-Özhan HE; Pinkhardt EH; Uttner I; Kassubek J; Ludolph AC; Lulé D
    J Neurol; 2015 Aug; 262(8):1918-26. PubMed ID: 26041615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emphasizing speed or accuracy in an eye-tracking version of the Trail-Making-Test: Towards experimental diagnostics for decomposing executive functions.
    Recker L; Foerster RM; Schneider WX; Poth CH
    PLoS One; 2022; 17(9):e0274579. PubMed ID: 36094948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
    Hurtado-Pomares M; Terol-Cantero MC; Sánchez-Pérez A; Leiva-Santana C; Peral-Gómez P; Valera-Gran D; Navarrete-Muñoz EM
    PLoS One; 2018; 13(11):e0207698. PubMed ID: 30452476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Arrows and Colors Cognitive Test (ACCT): A new verbal-motor free cognitive measure for executive functions in ALS.
    Poletti B; Carelli L; Faini A; Solca F; Meriggi P; Lafronza A; Ciringione L; Pedroli E; Ticozzi N; Ciammola A; Cipresso P; Riva G; Silani V
    PLoS One; 2018; 13(8):e0200953. PubMed ID: 30091987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinimetric validity of the Trail Making Test Czech version in Parkinson's disease and normative data for older adults.
    Bezdicek O; Stepankova H; Axelrod BN; Nikolai T; Sulc Z; Jech R; Růžička E; Kopecek M
    Clin Neuropsychol; 2017; 31(sup1):42-60. PubMed ID: 28534428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of verbs related to body movement in amyotrophic lateral sclerosis (ALS) and Parkinson's Disease (PD).
    Cousins KAQ; Ash S; Grossman M
    Cortex; 2018 Mar; 100():127-139. PubMed ID: 28969902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A first approach to a neuropsychological screening tool using eye-tracking for bedside cognitive testing based on the Edinburgh Cognitive and Behavioural ALS Screen.
    Keller J; Krimly A; Bauer L; Schulenburg S; Böhm S; Aho-Özhan HEA; Uttner I; Gorges M; Kassubek J; Pinkhardt EH; Abrahams S; Ludolph AC; Lulé D
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):443-450. PubMed ID: 28420245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETMT: A Tool for Eye-Tracking-Based Trail-Making Test to Detect Cognitive Impairment.
    Chandrasekharan J; Joseph A; Ram A; Nollo G
    Sensors (Basel); 2023 Aug; 23(15):. PubMed ID: 37571630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which motor-cognitive abilities underlie the digital Trail-Making Test? Decomposing various test scores to detect cognitive impairment in Parkinson's disease-Pilot study.
    Park SY; Schott N
    Appl Neuropsychol Adult; 2022 Nov; ():1-15. PubMed ID: 36412487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compensating for verbal-motor deficits in neuropsychological assessment in movement disorders: sensitivity and specificity of the ECAS in Parkinson's and Huntington's diseases.
    Carelli L; Solca F; Migliore S; Torre S; Brugnera A; Mancini F; Tagini S; Ferrucci R; Maffi S; Ceccarelli C; Pasquini J; Sassone J; Squitieri F; Ciammola A; Silani V; Poletti B
    Neurol Sci; 2021 Dec; 42(12):4997-5006. PubMed ID: 33728549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Executive function in Parkinson's disease].
    Kanazawa A; Mizuno Y; Narabayashi H
    Rinsho Shinkeigaku; 2001; 41(4-5):167-72. PubMed ID: 11676156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy.
    Costabile T; Pane C; Aurisicchio L; Salvati A; Lieto M; Peluso S; Reia A; De Lucia N; De Rosa A; Filla A; De Michele G; Saccà F
    Neurol Sci; 2020 Dec; 41(12):3633-3641. PubMed ID: 32462388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the motor account of amyotrophic lateral sclerosis: Verbal humour and its relationship with the cognitive and pragmatic profile.
    Bambini V; Bischetti L; Bonomi CG; Arcara G; Lecce S; Ceroni M
    Int J Lang Commun Disord; 2020 Sep; 55(5):751-764. PubMed ID: 32725835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis.
    Keller J; Gorges M; Aho-Özhan HE; Uttner I; Schneider E; Kassubek J; Pinkhardt EH; Ludolph AC; Lulé D
    J Vis Exp; 2016 Oct; (116):. PubMed ID: 27768047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal immersive trail making-virtual reality paradigm to study cognitive-motor interactions.
    Plotnik M; Ben-Gal O; Doniger GM; Gottlieb A; Bahat Y; Cohen M; Kimel-Naor S; Zeilig G; Beeri MS
    J Neuroeng Rehabil; 2021 May; 18(1):82. PubMed ID: 34001179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between neuropsychological tests and driver's license renewal tests in Parkinson's disease.
    Badenes D; Garolera M; Casas L; Cejudo-Bolivar JC; Zaragoza S; Calzado N; Aguilar M
    Traffic Inj Prev; 2018 Feb; 19(2):125-132. PubMed ID: 28759268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can executive cognitive measures differentiate between patients with spinal- and bulbar-onset amyotrophic lateral sclerosis?
    Zalonis I; Christidi F; Paraskevas G; Zabelis T; Evdokimidis I; Kararizou E
    Arch Clin Neuropsychol; 2012 May; 27(3):348-54. PubMed ID: 22403771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural substrate of cognitive theory of mind impairment in amyotrophic lateral sclerosis.
    Carluer L; Mondou A; Buhour MS; Laisney M; Pélerin A; Eustache F; Viader F; Desgranges B
    Cortex; 2015 Apr; 65():19-30. PubMed ID: 25618325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.